GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » CMIC HOLDINGS Co Ltd (TSE:2309) » Definitions » Debt-to-EBITDA

CMIC HOLDINGS Co (TSE:2309) Debt-to-EBITDA : 1.29 (As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is CMIC HOLDINGS Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

CMIC HOLDINGS Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円1,044 Mil. CMIC HOLDINGS Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円1,570 Mil. CMIC HOLDINGS Co's annualized EBITDA for the quarter that ended in Dec. 2023 was 円2,032 Mil. CMIC HOLDINGS Co's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 1.29.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for CMIC HOLDINGS Co's Debt-to-EBITDA or its related term are showing as below:

TSE:2309' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.17   Med: 2.67   Max: 4.18
Current: 0.27

During the past 13 years, the highest Debt-to-EBITDA Ratio of CMIC HOLDINGS Co was 4.18. The lowest was 0.17. And the median was 2.67.

TSE:2309's Debt-to-EBITDA is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: 1.915 vs TSE:2309: 0.27

CMIC HOLDINGS Co Debt-to-EBITDA Historical Data

The historical data trend for CMIC HOLDINGS Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CMIC HOLDINGS Co Debt-to-EBITDA Chart

CMIC HOLDINGS Co Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.59 3.76 2.25 1.19 0.17

CMIC HOLDINGS Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.67 0.62 0.35 -0.60 1.29

Competitive Comparison of CMIC HOLDINGS Co's Debt-to-EBITDA

For the Diagnostics & Research subindustry, CMIC HOLDINGS Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CMIC HOLDINGS Co's Debt-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, CMIC HOLDINGS Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where CMIC HOLDINGS Co's Debt-to-EBITDA falls into.



CMIC HOLDINGS Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

CMIC HOLDINGS Co's Debt-to-EBITDA for the fiscal year that ended in Sep. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1123 + 1804) / 16792
=0.17

CMIC HOLDINGS Co's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1044 + 1570) / 2032
=1.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


CMIC HOLDINGS Co  (TSE:2309) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


CMIC HOLDINGS Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of CMIC HOLDINGS Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


CMIC HOLDINGS Co (TSE:2309) Business Description

Traded in Other Exchanges
N/A
Address
Hamamatsucho Building, 1-1-1 Shibaura, Minato-ku, Tokyo, JPN, 105-0023
CMIC HOLDINGS Co Ltd is a Japan-based management consulting company. It contributes to the development of the medical and healthcare field. The company is mainly engaged in Contract Research Organization (CRO), Contract Development and Manufacturing (CDMO), Contract Sales Organization (CSO), Innovative Pharma Model (IPM) and healthcare business. CMIC support a wide range of pharmaceutical management services such as data management, statistical analysis, medicine consulting, medical writing, audit, and analytical tests, clinical trials for the medical and pharmaceutical industry, human resource services. It is also engaged in providing sales and marketing support for pharmaceuticals.

CMIC HOLDINGS Co (TSE:2309) Headlines

No Headlines